Strahlenzentrum Hamburg-MVZ

What Strahlenzentrum Hamburg-MVZ does

Strahlenzentrum Hamburg-MVZ is a privately held, physician-led outpatient medical care center (Medizinisches Versorgungszentrum, MVZ) specializing in radiation therapy and radiosurgery, founded in 2007 by Prof. Dr. med. Fabian Fehlauer and headquartered in Hamburg-Langenhorn with a satellite site in Elmshorn, Schleswig-Holstein opened in 2013. The center treats patients with malignant tumors (prostate, breast, lung, brain, spinal, liver, pancreatic, kidney, head-and-neck, and other cancers) as well as benign inflammatory and degenerative musculoskeletal conditions, using a portfolio that combines the CyberKnife VSI robotic radiosurgery system (installed 2011), Versa HD linear accelerators with IGRT/CBCT, and Vision RT surface-guided radiation therapy (installed 2019) — a combination it positions as unique among certified outpatient facilities in Germany. Röntgenreizbestrahlung (low-dose X-ray stimulation therapy) is offered as a GKV-covered treatment for chronic joint, tendon, and soft-tissue conditions, with over 50,000 cumulative procedures and more than 2,000 patients treated annually.

Name

Strahlenzentrum Hamburg-MVZ

Legal name

Strahlenzentrum Hamburg MVZ

Website

https://strahlenzentrum-hamburg.de

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Strahlenzentrum Hamburg-MVZ is a physician-led outpatient radiation therapy and radiosurgery center in Hamburg and Elmshorn offering CyberKnife, linear-accelerator, SGRT, and low-dose X-ray stimulation treatments to cancer and benign-condition patients across North Germany.

Ownership category

akta.pro rank

Product category

Outpatient Radiation Therapy and Radiosurgery

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

Keywords

• Radiation therapy services
• Robotic radiosurgery treatment
• CyberKnife cancer treatment
• Outpatient oncology care
• Precision radiotherapy

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Radiation Therapy and Radiosurgery Services: Ambulatory medical services reimbursed through statutory health insurance (GKV) and private health insurance (PKV). The center has contracts with numerous statutory and private health insurers for CyberKnife treatment. X-ray stimulation irradiation is recognized as a statutory health insurance benefit.
2. Consultation and Second Opinion Services: Initial consultations, second opinions, and follow-up care consultations as part of comprehensive patient treatment pathway.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Strahlenzentrum Hamburg-MVZ is an outpatient radiation therapy and radiosurgery center providing high-precision cancer treatment using CyberKnife robotic radiosurgery and linear accelerator-based photon therapy, along with low-dose X-ray stimulation therapy (Röntgenreizbestrahlung) for benign inflammatory and degenerative joint conditions. The center treats malignant tumors (prostate, breast, lung, brain, spine, liver, pancreatic, kidney cancers, metastases, lymphomas) and benign conditions (arthrosis, tendon irritation, heel spurs, Morbus Dupuytren) with submillimeter precision and individualized treatment protocols.

Product overview

Strahlenzentrum Hamburg-MVZ operates as an outpatient radiation therapy and radiosurgery center offering a comprehensive portfolio of cancer treatment and pain management services. The core offerings include CyberKnife Radiochirurgie (robotic-guided radiosurgery), conventional Strahlentherapie using linear accelerators, Vision RT (Surface Guided Radiation Therapy) as a positioning module, and Röntgenreizbestrahlung for pain management. The center operates two locations (Langenhorn and Elmshorn) and is Germany's only physician-led, certified outpatient facility offering both CyberKnife and modern high-precision radiation therapy under one roof, enabling selection of the optimal treatment approach for each patient.

Differentiator

Problem solved

Functional benefit

Brands

• CyberKnife Center Hamburg: A specialized center within Strahlenzentrum Hamburg offering robotic radiosurgery using the CyberKnife system for precise tumor treatment.

Products and services

• CyberKnife Radiochirurgie Robotic-guided radiosurgery system offering submillimeter-precise photon treatment for tumors throughout the body. The 'virtual scalpel' destroys diseased tissue while sparing healthy tissue, performed without surgery, anesthesia, or hospital stay. Typically completed in 1-5 outpatient sessions for many indications.
• Strahlentherapie (Linearbeschleuniger) Modern high-precision radiation therapy using the Versa HD linear accelerator for percutaneous photon therapy with ionizing radiation. Treatment is delivered externally over several weeks in daily sessions, targeting tumor cells by damaging their genetic material while minimizing load on healthy tissue. Equipped with IGRT and CBCT for precise tumor targeting.
• Vision RT (SGRT) Markerless Treatment Surface Guided Radiation Therapy using 20,000 light points and 3D cameras for submillimeter-precise, contactless patient positioning without skin markings or tattoos. Unique technology in all of Northern Germany, enabling markerless irradiation as a recognized positioning and treatment delivery service.
• Röntgenreizbestrahlung (X-ray Stimulation Therapy) Low-dose X-ray stimulation therapy for pain treatment of chronic inflammatory and degenerative joint, bone, cartilage, and soft tissue conditions such as arthrosis, tendon irritation, heel spurs, bursitis, Morbus Dupuytren, and Morbus Ledderhose. Delivered in 1-3 cycles of 3 sessions each, side-effect free, and covered by statutory health insurance. Up to 90% success rate.
• CyberKnife Prostata (Prostate Cancer Protocol) Specialized CyberKnife treatment protocol for prostate cancer using real-time tumor tracking with gold markers implanted in the prostate, enabling submillimeter accuracy with only 5 treatment sessions over 1-2 weeks. Designed to minimize long-term complications such as incontinence and erectile dysfunction compared to surgery or conventional radiotherapy, with 85-95% success rates.
• Zweitmeinung (Second Opinion) and Consultation Initial consultations, second opinions, and follow-up care consultations offered as part of the comprehensive patient treatment pathway, available via phone consultation, video conference, or in-person visit, with medical record upload capability up to 100 MB.

Quantifiable outcome

• 85-95% success rate for prostate cancer treatment with CyberKnife
• +4 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• University Medical Center Hamburg-Eppendorf (UCHH)coreStrategic or Co-development PartnerAcademic medical center partnership for interdisciplinary collaboration and patient care coordination. Located in Hamburg serving as referral and collaboration partner.
• Asklepios KlinikcoreStrategic or Co-development PartnerMajor hospital group partnership for patient referrals and interdisciplinary oncology care. One of the largest hospital operators in Germany.
• Marienkrankenhaus HamburgcoreStrategic or Co-development PartnerRegional hospital partnership for patient referrals and collaborative cancer treatment. Located in Hamburg.
• Klinikum ItzehoeminorStrategic or Co-development PartnerRegional hospital partnership for patient referrals from Schleswig-Holstein region. Located in Itzehoe.
• Jerusalem KrankenhausminorStrategic or Co-development PartnerRegional hospital partnership for patient referrals and collaborative care.
• Mammazentrum HamburgcoreStrategic or Co-development PartnerSpecialized breast cancer center partnership for coordinated breast cancer treatment and patient referrals.
• Immanuel DiakonieminorStrategic or Co-development PartnerDiakonie hospital group partnership for patient referrals and holistic care approaches.
• Krankenhaus Henstedt-UlzburgminorStrategic or Co-development PartnerLocal hospital partnership for patient referrals from the Henstedt-Ulzburg area.
• Evangelisches Amalie KrankenhausminorStrategic or Co-development PartnerRegional hospital partnership for patient referrals and collaborative oncology care.

Scale indicators4 records

Recent moves11 records

Expansion highlights5 records

Broad incumbents

• Helios Kliniken: Germany's largest private hospital operator (subsidiary of Fresenius) operating dozens of radiation oncology departments nationwide. Comparable as a large-scale provider of precision radiotherapy in Germany with broader geographic reach and integrated care offerings.
• Asklepios Kliniken: One of Germany's largest private hospital groups with multiple radiation oncology departments in Hamburg and across Germany. Strategic referral partner of Strahlenzentrum Hamburg but also offers competing integrated oncology services through its Hermann-Holthusen-Institut at AK St. Georg.
• Sana Kliniken: Private German hospital group with radiation therapy departments across multiple sites. Comparable as a multi-site private operator of oncology and radiotherapy services in the German healthcare market.
• Universitätsklinikum Hamburg-Eppendorf (UKE): Major academic medical center in Hamburg operating comprehensive radiation oncology, medical oncology, and surgical services. Listed as a strategic referral partner of Strahlenzentrum Hamburg while also offering competing radiotherapy capabilities in the same metropolitan region.
• Charité Berlin: Germany's largest university hospital with one of Europe's most prominent radiation oncology departments, including CyberKnife and proton therapy. Comparable at a much larger scale for advanced radiotherapy in the German market; previous employer of Dr. Sebastian Exner on the Strahlenzentrum team.
• GenesisCare: Global private cancer care provider operating radiotherapy centers across Europe (including Germany), Australia, and the US. Comparable as a large-scale precision radiation oncology operator; offers similar combination of conventional linacs and advanced technology.

Direct peers

• CyberKnife Salzburg: Austrian CyberKnife center explicitly listed as a technology collaboration and best-practice exchange partner of Strahlenzentrum Hamburg. Comparable as a CyberKnife-focused radiosurgery practice serving a German-speaking patient population.
• Europad Klinik Köln: German outpatient clinic operating CyberKnife radiosurgery and other specialized procedures. Directly comparable to Strahlenzentrum Hamburg as another physician-led CyberKnife center offering similar precision oncology services to German patients.

Emerging players

• MedAustron: Austrian particle therapy center offering advanced carbon-ion and proton therapy for cancer. Comparable as a Central-European precision radiotherapy center using cutting-edge technology; represents a different but adjacent modality competing for complex cancer cases.

Regional players

• MVZ Strahlentherapie Rhein-Main: German MVZ operating outpatient radiation oncology practices in the Rhine-Main region with linear accelerators and IMRT/VMAT services. Comparable as a private-practice MVZ model delivering precision radiotherapy outside of large hospital settings, but in a different German region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/strahlenzentrum-hamburg-mvz-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Strahlenzentrum Hamburg-MVZ